0000899243-21-037773.txt : 20210927
0000899243-21-037773.hdr.sgml : 20210927
20210927141830
ACCESSION NUMBER: 0000899243-21-037773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210826
FILED AS OF DATE: 20210927
DATE AS OF CHANGE: 20210927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHANNON TIMOTHY M
CENTRAL INDEX KEY: 0001207114
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38672
FILM NUMBER: 211280603
MAIL ADDRESS:
STREET 1: C/O CURAGEN CORP
STREET 2: 555LONG WHARF DR. 11TH FL.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARVINAS, INC.
CENTRAL INDEX KEY: 0001655759
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472566120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-535-1456
MAIL ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS INC.
DATE OF NAME CHANGE: 20181001
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC
DATE OF NAME CHANGE: 20151015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-26
0
0001655759
ARVINAS, INC.
ARVN
0001207114
SHANNON TIMOTHY M
C/O ARVINAS, INC., 5 SCIENCE PARK,
395 WINCHESTER AVENUE
NEW HAVEN
CT
06511
1
0
0
0
Common Stock
2021-08-26
4
S
0
11712
85.1238
D
2016347
I
See Footnote
Common Stock
2021-08-27
4
S
0
42655
85.3807
D
1973692
I
See Footnote
Common Stock
2021-08-27
4
S
0
2371
86.0553
D
1971321
I
See Footnote
Common Stock
2021-08-30
4
S
0
24607
85.1934
D
1946714
I
See Footnote
Common Stock
2021-08-30
4
S
0
25469
86.3997
D
1921245
I
See Footnote
Common Stock
2021-08-30
4
S
0
7581
87.5081
D
1913664
I
See Footnote
Common Stock
2021-08-30
4
S
0
1181
88.2226
D
1912483
I
See Footnote
Common Stock
80643
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 - $85.46, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 - $85.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.01 - $86.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 - $85.995, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.01 - $86.965, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.01 - $87.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.19 - $88.33, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes shares received by the Reporting Person in prior distributions.
By: /s/ Nancy Levenson, as Attorney-in-Fact for Timothy M. Shannon
2021-09-27